- Home
- PYCR vs VERA Comparison
PYCR vs VERA Comparison
Compare PYCR & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYCR
- VERA
- Stock Information
- Founded
- PYCR 1990
- VERA 2016
- Country
- PYCR United States
- VERA United States
- Employees
- PYCR N/A
- VERA N/A
- Industry
- PYCR Computer Software: Prepackaged Software
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- PYCR Technology
- VERA Health Care
- Exchange
- PYCR Nasdaq
- VERA Nasdaq
- Market Cap
- PYCR 2.6B
- VERA 2.5B
- IPO Year
- PYCR 2021
- VERA 2021
- Fundamental
- Price
- PYCR $16.40
- VERA $46.26
- Analyst Decision
- PYCR Buy
- VERA Strong Buy
- Analyst Count
- PYCR 16
- VERA 9
- Target Price
- PYCR $19.50
- VERA $54.33
- AVG Volume (30 Days)
- PYCR 932.7K
- VERA 1.1M
- Earning Date
- PYCR 11-06-2024
- VERA 11-07-2024
- Dividend Yield
- PYCR N/A
- VERA N/A
- EPS Growth
- PYCR N/A
- VERA N/A
- EPS
- PYCR N/A
- VERA N/A
- Revenue
- PYCR $678,836,000.00
- VERA N/A
- Revenue This Year
- PYCR $13.67
- VERA N/A
- Revenue Next Year
- PYCR $11.60
- VERA N/A
- P/E Ratio
- PYCR N/A
- VERA N/A
- Revenue Growth
- PYCR 17.45
- VERA N/A
- 52 Week Low
- PYCR $10.92
- VERA $12.28
- 52 Week High
- PYCR $22.66
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- PYCR 60.83
- VERA 54.02
- Support Level
- PYCR $16.51
- VERA $47.16
- Resistance Level
- PYCR $17.70
- VERA $51.61
- Average True Range (ATR)
- PYCR 0.58
- VERA 2.99
- MACD
- PYCR 0.08
- VERA 0.21
- Stochastic Oscillator
- PYCR 64.48
- VERA 52.82
About PYCR Paycor HCM Inc.
Paycor HCM provides payroll and human capital management solutions to small and midsize clients in the United States via a software-as-a-service model. Alongside core payroll functionality, the firm's platform offers a suite of HCM solutions including talent management and time and attendance software, third-party integration capabilities, and industry-specific configurations. The firm targets customers with 10-1,000 employees and had over 30,500 customers as of June 2024.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.